SOPHiA GENETICS
SOPH
34 hedge funds and large institutions have $80.2M invested in SOPHiA GENETICS in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 34 → 34 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.66% less ownership
Funds ownership: 28.49% → 27.82% (-0.66%)
12% less capital invested
Capital invested by funds: $90.9M → $80.2M (-$10.8M)
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.79M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$466K |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$70K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$42.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Principal Financial Group
Des Moines,
Iowa
|
-$1.99M |
| 2 |
PVI
Pura Vida Investments
New York
|
-$1.08M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$312K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$287K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$93.1K |
SOPH Hedge Fund Activity: Q2 2023 in Review
34 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q2 2023, worth a combined $80.2M — down 12% from $90.9M a quarter earlier.
Fund positioning in SOPH was balanced in Q2 2023: 3 funds opened new positions, 3 closed out, 7 added to existing stakes and 11 trimmed.
The largest buyer was Millennium Management, adding an estimated $1.79M. The largest seller was Principal Financial Group, cutting an estimated $1.99M.
- 34 institutional investors held SOPHiA GENETICS (SOPH) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $80.2M of SOPHiA GENETICS stock for Q2 2023, down 12% quarter-over-quarter.
- 3 funds opened new SOPHiA GENETICS positions in Q2 2023 and 3 closed out, a net change of 0 holders.
- The largest SOPHiA GENETICS buyer in Q2 2023 was Millennium Management, an estimated $1.79M added.
- The largest SOPHiA GENETICS seller in Q2 2023 was Principal Financial Group, an estimated $1.99M sold.
Based on aggregated 13F filings for Q2 2023.